Clinical significance of the rivaroxaban–dronedarone interaction: insights from physiologically based pharmacokinetic modelling

Patients with atrial fibrillation may require rhythm control therapy in addition to anticoagulation therapy for the prevention of stroke. Since 2012, the European Society of Cardiology and European Heart Rhythm Association guidelines have recommended non-vitamin K antagonist oral anticoagulants, inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hügl, Burkhard, Horlitz, Marc, Fischer, Kerstin, Kreutz, Reinhold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938521/
https://www.ncbi.nlm.nih.gov/pubmed/36820238
http://dx.doi.org/10.1093/ehjopen/oead004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938521/
https://www.ncbi.nlm.nih.gov/pubmed/36820238
http://dx.doi.org/10.1093/ehjopen/oead004

Ejemplares similares